RE: Welcome to new CEOThe last pargraph of the NR states:
"Current interim-CEO Mr. Kevin O'Neill was quoted, "We are delighted to have David as our CEO and look forward to the success of employing his impressive array of skills and experience to implement Pyng Medical Corp's strategic plan. This will include growing the sales of our successful product the F.A.S.T.1(TM) and derivates in new markets. Also of great importance will be drawing on David's previous successes in developing new profitable products for Pyng Medical, including potential acquisitions of other medical device companies as an efficient way to grow and further diversify Pyng's revenues."
It is clear that Pyng is looking to the future and growing the company by diversifying. IMO perhaps the new CEO brings some direct experience with companies with which Pyng may be interested in acquiring or merging. Growth is key to increasing the share price. The new CEO will be expected to provide results and these results, in large part, should be measured by the PYT share price.